IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.967
NA - Nord America 7.057
AS - Asia 3.930
SA - Sud America 1.569
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 98
OC - Oceania 7
Totale 20.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.917
RU - Federazione Russa 4.036
SG - Singapore 1.687
BR - Brasile 1.341
CN - Cina 1.107
IE - Irlanda 1.051
SE - Svezia 954
HK - Hong Kong 448
DE - Germania 403
UA - Ucraina 395
IT - Italia 285
FR - Francia 222
FI - Finlandia 221
VN - Vietnam 201
GB - Regno Unito 161
IN - India 105
PL - Polonia 79
AR - Argentina 64
CA - Canada 56
BD - Bangladesh 51
IQ - Iraq 43
EC - Ecuador 41
MX - Messico 41
TR - Turchia 36
CO - Colombia 35
JP - Giappone 34
AT - Austria 29
MA - Marocco 28
UZ - Uzbekistan 27
PK - Pakistan 26
VE - Venezuela 26
ID - Indonesia 21
IR - Iran 21
NL - Olanda 21
ZA - Sudafrica 21
BE - Belgio 17
CL - Cile 16
CZ - Repubblica Ceca 15
KE - Kenya 15
ES - Italia 13
JM - Giamaica 13
PY - Paraguay 13
BO - Bolivia 11
KR - Corea 11
UY - Uruguay 11
JO - Giordania 10
MY - Malesia 10
PE - Perù 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
CR - Costa Rica 9
DZ - Algeria 9
IL - Israele 9
LT - Lituania 8
NP - Nepal 8
RS - Serbia 8
AU - Australia 7
EG - Egitto 7
GR - Grecia 7
PH - Filippine 7
TN - Tunisia 7
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
NO - Norvegia 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
PT - Portogallo 5
BG - Bulgaria 4
LB - Libano 4
TT - Trinidad e Tobago 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
LK - Sri Lanka 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
KW - Kuwait 2
MM - Myanmar 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BW - Botswana 1
Totale 20.620
Salva come PNG Salva come JPEG
Città #
Moscow 1.259
Dublin 1.050
Singapore 896
Jacksonville 783
Ashburn 773
Chandler 712
Dallas 703
Nyköping 594
Hong Kong 446
Dearborn 435
Beijing 378
San Jose 264
Council Bluffs 253
The Dalles 191
Princeton 181
Medford 176
Cambridge 173
Lauterbourg 154
Los Angeles 152
Des Moines 97
Ann Arbor 94
Boardman 93
Buffalo 89
Ho Chi Minh City 88
São Paulo 85
Munich 83
Warsaw 72
New York 71
Messina 64
San Mateo 61
Tianjin 56
Jinan 49
Belo Horizonte 46
Wilmington 46
Guangzhou 44
Turku 39
Rio de Janeiro 38
Santa Clara 33
Woodbridge 33
Columbus 27
Hanoi 27
Orem 27
Chennai 26
Vienna 26
Curitiba 25
Lancaster 25
Redondo Beach 24
Shenyang 24
Tokyo 24
Haikou 23
Nanjing 23
Frankfurt am Main 22
Tashkent 22
Houston 21
Seattle 21
Shanghai 21
Brasília 20
Denver 20
Phoenix 20
Salvador 19
Atlanta 18
Baghdad 18
Brussels 17
Campinas 16
Chicago 16
Hebei 16
St Petersburg 16
Ardabil 15
Milan 15
Shenzhen 15
Montreal 14
Washington 14
Johannesburg 13
London 13
Ningbo 13
Quito 13
San Francisco 13
Stockholm 13
Brooklyn 12
Fuzhou 12
Taiyuan 12
Taizhou 12
Boston 11
Dhaka 11
Düsseldorf 11
Hefei 11
Manchester 11
Mexico City 11
Nanchang 11
Porto Alegre 11
Pune 11
Francofonte 10
Istanbul 10
Manaus 10
Mumbai 10
Nairobi 10
Pelotas 10
Sorocaba 10
Windsor 10
Augusta 9
Totale 11.845
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 253
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 210
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 202
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 191
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 189
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 189
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 188
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 186
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 185
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 179
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 178
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 177
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 177
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 177
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 176
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 175
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 173
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 171
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 170
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 170
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 168
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 168
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 167
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 166
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 163
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 162
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 162
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 161
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 160
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 159
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 159
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 159
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 158
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 153
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 153
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 152
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 152
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 150
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 149
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 149
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 149
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 148
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 147
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 147
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 146
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 145
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 144
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 142
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 141
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 140
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 140
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 139
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 139
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 137
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 135
Electronegativity of zeolites in relation to catalytic activity in the conversion of methanol to hydrocarbons 135
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 135
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 134
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 133
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 129
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 128
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 128
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 128
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 126
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 126
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 125
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 125
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 123
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 122
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 122
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 122
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 121
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 119
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 119
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 118
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 117
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 117
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 116
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 116
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 115
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 111
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 111
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 110
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 110
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 109
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 109
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 109
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 109
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 107
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 107
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 107
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 106
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 106
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 106
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 105
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 105
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 104
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 103
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 103
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 103
Totale 14.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.067 0 136 34 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024514 37 94 75 41 57 96 7 27 0 15 6 59
2024/20253.128 62 25 52 167 140 71 59 712 838 187 234 581
2025/20269.280 389 677 716 795 655 2.142 1.134 1.121 1.020 331 180 120
2026/2027361 122 239 0 0 0 0 0 0 0 0 0 0
Totale 20.729